- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
ChristianaCare Innovates Diabetes Care for Patients With Poorly Controlled Disease
On this episode of Managed Care Cast, we speak with experts from ChristianaCare, which implemented a diabetes pilot program at 4 of its primary care sites in 2019 and saw its population of patients with well-controlled disease grow by 16%.
According to the CDC’s 2020 National Diabetes Statistics Report, 34.2 million Americans have diabetes, 88 million adults have prediabetes, and type 1 and type 2 are both increasing in incidence among younger individuals.
On this episode of Managed Care Cast, we speak with experts from ChristianaCare, one of the largest health care providers in the mid-Atlantic region, serving patients in Delaware and parts of Maryland, New Jersey, and Pennsylvania.
Hoping to increase the percentage of their patients with diabetes who have a hemoglobin A1C of 9% or lower, in 2019, ChristianaCare implemented a diabetes pilot program at 4 of its primary care sites, partnering each site with an endocrinologist and embedding a behavioral counselor at Primary Care Concord in Chadds Ford, Pennsylvania. With an original goal of growing this patient group by 10% by July of 2019, they instead saw 16% growth.
Marina V. Zeltser, MD, MBA, assistant chief medical information officer for population health and director of population health analytics at ChristianaCare; Raymond Carter, MD, clinical leader of primary care at Primary Care Concord; and Edward Feuer, MA, the behavioral health counselor embedded at Dr Carter’s practice sat down with us to discuss the pilot program, the team-based approach with results that exceeded ChristianaCare’s original goals, and how they would like to see the program expand going forward.
Listen above or through one of these podcast services:
Related Articles:
Experts Discuss Benefits, Limitations of Pediatric Obesity Interventions
Study Weighs Perceived Benefits, Costs of RDM Adoption for Diabetes Management
Recognizing the Role of Systemic Racism in Diabetes Disparities
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
